Direktorat Registrasi ObatValid

SANDOSTATIN

Claim this product
BPOM Number
DKI2265700143A1
Approved
7 March 2025
Expiry
23 April 2023
Form
INJEKSI

About This Registration

SANDOSTATIN is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2265700143A1. Its current registration status is Valid, with the licence valid until 23 April 2023. The product is registered to NOVARTIS INDONESIA - INDONESIA. BPOM first approved this registration in January 2023. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 5 AMPUL @ 1 ML
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

OCTREOTIDE

Market Intelligence

Owner Portfolio
NOVARTIS INDONESIA - INDONESIA holds 144 BPOM registrations
Manufacturer Scale
NOVARTIS INDONESIA - INDONESIA produces 144 registered products
Registration Age
Registered for 3 years, 8 months
Expiry Status
Expired 1252 days ago

FDA Cross-Reference

via openFDA
Generic Name
OCTREOTIDE ACETATE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAVENOUS

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1